Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Lamotrigine may be effective in reducing pain, numbness, tingling, and other
symptoms of peripheral neuropathy. It is not yet known whether lamotrigine is effective in
treating peripheral neuropathy caused by chemotherapy.
PURPOSE: This randomized phase III trial is studying how well lamotrigine works in reducing
pain, numbness, tingling, and other symptoms of peripheral neuropathy caused by chemotherapy
in patients with cancer.